Abstract
Late complications in type 2 diabetic patients are commonly associated with accelerated development of atherosclerosis. In type 2 diabetes mellitus, non-enzymatic glycosylation of apo-B that is a function of hyperglycaemia is an efficient biochemical way of low-density lipoprotein atherogenic modification. So, proper metabolic control is needed to prevent late complications of diabetes. The study was performed to estimate the effects of time-released garlic powder tablet Allicor on the parameters of metabolic control and plasma lipids in type 2 diabetes mellitus. The metabolic action of Allicor was investigated in the 4-week double-blinded placebo-controlled study in 60 type 2 diabetic patients. Fasting blood glucose was measured daily, and serum fructosamine as well as cholesterol and triglyceride levels were determined at the baseline, after 1, 2, 3 and 4 weeks. It has been demonstrated that treatment with Allicor resulted in better metabolic control due to the lowering of fasting blood glucose, serum fructosamine and serum triglyceride levels. The results of this study may allow recommending garlic powder tablets Allicor for the treatment of type 2 diabetes mellitus along with dietary treatment and/or sulfonylurea derivatives to achieve better metabolic control. The benefits from garlic preparations may lead to the reduction of cardiovascular risk in diabetic patients.
Similar content being viewed by others
References
Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR (1991) Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 90:56S–61S
Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T (1993) Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. Am J Epidemiol 137:1328–1340
Schwartz CJ, Valente AJ, Sprague EA (1993) A modern view of atherogenesis. Am J Cardiol 71:9B–14B
Pyorala K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463–524
Nesto R (2001) CHD: a major burden in type 2 diabetes. Acta Diabetol 38(1):S3–S8
Swanston-Flatt SK, Flatt PR, Day C, Bailey CJ (1991) Traditional dietary adjuncts for the treatment of diabetes mellitus. Proc Nutr Soc 50:641–651
Harenberg J, Giese C, Zimmermann R (1988) Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 74:247–249
Berthold HK, Sudhop T (1998) Garlic preparations for prevention of atherosclerosis. Curr Opin Lipidol 9:565–569
Wang HX, Ng TB (1999) Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci 65:2663–2677
Kruse-Jarres JD, Jarausch J, Lehmann P, Vogt BW, Rietz P (1989) A new colorimetric method for the determination of fructosamine. Lab Med 13:245–253
Bordia AK, Joshi HK, Sanadhya YK, Bhu N (1977) Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 28:155–159
Lau B, Lam F, Wang-Chen R (1987) Effect of odor-modified garlic preparation on blood lipids. Nutr Res 7:139–149
Phelps S, Harris WS (1993) Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 28:475–477
Campbell JH, Efendy JL, Smith NJ, Campbell GR (2001) Molecular basis by which garlic suppresses atherosclerosis. J Nutr 131:1006S–1009S
Block E (1985) The chemistry of garlic and onions. Sci Am 252:114–119
Orekhov AN, Tertov VV (1997) In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids 32:1055–1060
Yeh YY, Liu L (2001) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 131:989S–993S
Ledet T, Rasmussen LM, Heickendorff L, Barfod K, Thogersen VB (1990) The nature of large vessel disease in diabetes mellitus. J Diabet Complications 4:63–65
Koskinen SV, Reunanen AR, Martelin TP, Valkonen T (1998) Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus. Am J Public Health 88:765–770
Goraya TY, Leibson CL, Palumbo PJ (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40:946–953
Nesto RW, Rutter MK (2002) Impact of the atherosclerotic process in patients with diabetes. Acta Diabetol 39(2):S22–S28
Koskinen P, Irjala K, Viikari J, Panula O, Matikainen MT (1987) Serum fructosamine in the assessment of glycaemic control in diabetes mellitus. Scand J Clin Lab Invest 47:285–292
Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D (1982) Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283–291
Wiklund O, Witztum JL, Carew TE, Pittman RC, Elam RL, Steinberg D (1987) Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. J Lipid Res 28:1098–1109
Witztum JL, Koschinsky T (1989) Metabolic and immunological consequences of glycation of low density lipoproteins. Prog Clin Biol Res 304:219–234
Brownlee M, Vlassara H, Cerami A (1985) Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34:938–941
Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434–6438
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Mathew PT, Augusti KT (1973) Studies on the effect of allicin (diallyl disulphide-oxide) on alloxan diabetes. I. Hypoglycaemic action and enhancement of serum insulin effect and glycogen synthesis. Indian J Biochem Biophys 10:209–212
Jain RC, Vyas CR, Mahatma OP (1973) Hypoglycaemic action of onion and garlic. Lancet 2:1491
Jain RC, Vyas CR (1974) Hypoglycaemia action of onion on rabbits. Br Med J 2:730
Jain RC, Vyas CR (1975) Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 28:684–685
Augusti KT, Mathew PT (1975) Effect of allicin on certain enzymes of liver after a short term feeding to normal rats. Experientia 31:148–149
Begum H, Bari MA (1985) Effect of garlic oil on the pancreas of experimental diabetes in guineapigs. Bangladesh Med Res Counc Bull 11:64–68
Sheela CG, Augusti KT (1992) Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J Exp Biol 30:523–526
Sheela CG, Kumud K, Augusti KT (1995) Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta Med 61:356–357
Augusti KT, Sheela CG (1996) Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia 52:115–120
Farva D, Goji IA, Joseph PK, Augusti KT (1986) Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J Biochem Biophys 23:24–27
Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR (1990) Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 33:462–464
Ohaeri OC (2001) Effect of garlic oil on the levels of various enzymes in the serum and tissue of streptozotocin diabetic rats. Biosci Rep 21:19–24
Patumraj S, Tewit S, Amatyakul S (2000) Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv 7:91–96
Sitprija S, Plengvidhya C, Kangkaya V, Bhuvapanich S, Tunkayoon M (1987) Garlic and diabetes mellitus phase II clinical trial. J Med Assoc Thai 70(2):223–227
Melchinskaya EN, Popovtseva ON, Gromnatskii NI (1997) Immunologic aspects of alisate in diabetes mellitus patients. Biull Eksp Biol Med 124:595–597
Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105(3):310–315
Ide N, Lau BH (1999) Aged garlic extract attenuates intracellular oxidative stress. Phytomedicine 6:125–131
Sobenin IA, Maksumova MA, Slavina ES, Balabolkin MI, Orekhov AN (1994) Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages. Atherosclerosis 105:159–163
Iberl B, Winkler G, Miller B, Knobloch K (1990) Quantitative determination of allicin and alliin from garlic by HPLC. Planta Med 56:320–326
Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y (2001) Intake of garlic and its bioactive components. J Nutr 131:955S–962S
Orekhov AN, Tertov VV, Sobenin IA, Pivovarova EM (1995) Direct anti-atherosclerosis-related efects of garlic. Ann Med 27:63–65
Orekhov AN, Grunwald J (1997) Effects of garlic on atherosclerosis. Nutrition 13:656–663
Acknowledgments
The authors thank the participants of this study for their time, effort and support. This work was supported with grant from the Institute for Atherosclerosis Research, Moscow, Russia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sobenin, I.A., Nedosugova, L.V., Filatova, L.V. et al. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetol 45, 1–6 (2008). https://doi.org/10.1007/s00592-007-0011-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-007-0011-x